Limited coverage drugs – mercaptopurine

Last updated on October 6, 2022

Special Authority requests can now be submitted online. It's simple and quick!

Generic Name / Strength / Form
mercaptopurine

Criteria	Approval period
1. Diagnosis of ulcerative colitis. OR 2. Diagnosis of autoimmune hepatitis. OR 3. Diagnosis of inflammatory bowel disease. OR 4. Diagnosis of Crohn's disease.	Indefinite

Criteria

Approval period

1. Diagnosis of ulcerative colitis.

2. Diagnosis of autoimmune hepatitis.

3. Diagnosis of inflammatory bowel disease.

4. Diagnosis of Crohn's disease.

Indefinite

Practitioner exemptions

No practitioner exemptions

Special notes

For any cancer related condition, please contact the British Columbia Cancer Agency at (604) 877-6098 ext. 4610.

Special Authority request form(s)

Log in to eForms
Online Forms (PDF, 524KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Limited coverage drugs – mercaptopurine

Practitioner exemptions

Special notes

Special Authority request form(s)